Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Throat Lozenges Market

ID: MRFR/Pharma/0705-CR
123 Pages
Nidhi Mandole
Last Updated: April 02, 2026

Throat Lozenges Market Research Report: Information by Type (Hard Candy Lozenges, Soft Lozenges, And Compressed Lozenges), By Ingredient (Menthol, Mint, Eucalyptus Oil, Peppermint Oil, Honey & Ginger, Lemon, and Others), By Indication (Sore Throat, Cough and Cold, and Throat Diseases), And by Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Throat Lozenges Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Type (USD Billion)
  49.     4.1.1 hard candy lozenges
  50.     4.1.2 soft lozenges
  51.     4.1.3 compressed lozenges
  52.   4.2 Healthcare, BY Ingredient (USD Billion)
  53.     4.2.1 menthol
  54.     4.2.2 mint
  55.     4.2.3 eucalyptus oil
  56.     4.2.4 peppermint oil
  57.     4.2.5 honey & ginger
  58.     4.2.6 lemon
  59.     4.2.7 others
  60.   4.3 Healthcare, BY Indication (USD Billion)
  61.     4.3.1 sore throat
  62.     4.3.2 cough and cold
  63.     4.3.3 throat diseases
  64.   4.4 Healthcare, BY Region (USD Billion)
  65.     4.4.1 North America
  66.       4.4.1.1 US
  67.       4.4.1.2 Canada
  68.     4.4.2 Europe
  69.       4.4.2.1 Germany
  70.       4.4.2.2 UK
  71.       4.4.2.3 France
  72.       4.4.2.4 Russia
  73.       4.4.2.5 Italy
  74.       4.4.2.6 Spain
  75.       4.4.2.7 Rest of Europe
  76.     4.4.3 APAC
  77.       4.4.3.1 China
  78.       4.4.3.2 India
  79.       4.4.3.3 Japan
  80.       4.4.3.4 South Korea
  81.       4.4.3.5 Malaysia
  82.       4.4.3.6 Thailand
  83.       4.4.3.7 Indonesia
  84.       4.4.3.8 Rest of APAC
  85.     4.4.4 South America
  86.       4.4.4.1 Brazil
  87.       4.4.4.2 Mexico
  88.       4.4.4.3 Argentina
  89.       4.4.4.4 Rest of South America
  90.     4.4.5 MEA
  91.       4.4.5.1 GCC Countries
  92.       4.4.5.2 South Africa
  93.       4.4.5.3 Rest of MEA
  94. 5 SECTION V: COMPETITIVE ANALYSIS
  95.   5.1 Competitive Landscape
  96.     5.1.1 Overview
  97.     5.1.2 Competitive Analysis
  98.     5.1.3 Market share Analysis
  99.     5.1.4 Major Growth Strategy in the Healthcare
  100.     5.1.5 Competitive Benchmarking
  101.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  102.     5.1.7 Key developments and growth strategies
  103.       5.1.7.1 New Product Launch/Service Deployment
  104.       5.1.7.2 Merger & Acquisitions
  105.       5.1.7.3 Joint Ventures
  106.     5.1.8 Major Players Financial Matrix
  107.       5.1.8.1 Sales and Operating Income
  108.       5.1.8.2 Major Players R&D Expenditure. 2023
  109.   5.2 Company Profiles
  110.     5.2.1 Reckitt Benckiser (GB)
  111.       5.2.1.1 Financial Overview
  112.       5.2.1.2 Products Offered
  113.       5.2.1.3 Key Developments
  114.       5.2.1.4 SWOT Analysis
  115.       5.2.1.5 Key Strategies
  116.     5.2.2 Procter & Gamble (US)
  117.       5.2.2.1 Financial Overview
  118.       5.2.2.2 Products Offered
  119.       5.2.2.3 Key Developments
  120.       5.2.2.4 SWOT Analysis
  121.       5.2.2.5 Key Strategies
  122.     5.2.3 Pfizer (US)
  123.       5.2.3.1 Financial Overview
  124.       5.2.3.2 Products Offered
  125.       5.2.3.3 Key Developments
  126.       5.2.3.4 SWOT Analysis
  127.       5.2.3.5 Key Strategies
  128.     5.2.4 Bayer (DE)
  129.       5.2.4.1 Financial Overview
  130.       5.2.4.2 Products Offered
  131.       5.2.4.3 Key Developments
  132.       5.2.4.4 SWOT Analysis
  133.       5.2.4.5 Key Strategies
  134.     5.2.5 GlaxoSmithKline (GB)
  135.       5.2.5.1 Financial Overview
  136.       5.2.5.2 Products Offered
  137.       5.2.5.3 Key Developments
  138.       5.2.5.4 SWOT Analysis
  139.       5.2.5.5 Key Strategies
  140.     5.2.6 Haleon (GB)
  141.       5.2.6.1 Financial Overview
  142.       5.2.6.2 Products Offered
  143.       5.2.6.3 Key Developments
  144.       5.2.6.4 SWOT Analysis
  145.       5.2.6.5 Key Strategies
  146.     5.2.7 Church & Dwight (US)
  147.       5.2.7.1 Financial Overview
  148.       5.2.7.2 Products Offered
  149.       5.2.7.3 Key Developments
  150.       5.2.7.4 SWOT Analysis
  151.       5.2.7.5 Key Strategies
  152.     5.2.8 MediNatura (DE)
  153.       5.2.8.1 Financial Overview
  154.       5.2.8.2 Products Offered
  155.       5.2.8.3 Key Developments
  156.       5.2.8.4 SWOT Analysis
  157.       5.2.8.5 Key Strategies
  158.   5.3 Appendix
  159.     5.3.1 References
  160.     5.3.2 Related Reports
  161. 6 LIST OF FIGURES
  162.   6.1 MARKET SYNOPSIS
  163.   6.2 NORTH AMERICA MARKET ANALYSIS
  164.   6.3 US MARKET ANALYSIS BY TYPE
  165.   6.4 US MARKET ANALYSIS BY INGREDIENT
  166.   6.5 US MARKET ANALYSIS BY INDICATION
  167.   6.6 CANADA MARKET ANALYSIS BY TYPE
  168.   6.7 CANADA MARKET ANALYSIS BY INGREDIENT
  169.   6.8 CANADA MARKET ANALYSIS BY INDICATION
  170.   6.9 EUROPE MARKET ANALYSIS
  171.   6.10 GERMANY MARKET ANALYSIS BY TYPE
  172.   6.11 GERMANY MARKET ANALYSIS BY INGREDIENT
  173.   6.12 GERMANY MARKET ANALYSIS BY INDICATION
  174.   6.13 UK MARKET ANALYSIS BY TYPE
  175.   6.14 UK MARKET ANALYSIS BY INGREDIENT
  176.   6.15 UK MARKET ANALYSIS BY INDICATION
  177.   6.16 FRANCE MARKET ANALYSIS BY TYPE
  178.   6.17 FRANCE MARKET ANALYSIS BY INGREDIENT
  179.   6.18 FRANCE MARKET ANALYSIS BY INDICATION
  180.   6.19 RUSSIA MARKET ANALYSIS BY TYPE
  181.   6.20 RUSSIA MARKET ANALYSIS BY INGREDIENT
  182.   6.21 RUSSIA MARKET ANALYSIS BY INDICATION
  183.   6.22 ITALY MARKET ANALYSIS BY TYPE
  184.   6.23 ITALY MARKET ANALYSIS BY INGREDIENT
  185.   6.24 ITALY MARKET ANALYSIS BY INDICATION
  186.   6.25 SPAIN MARKET ANALYSIS BY TYPE
  187.   6.26 SPAIN MARKET ANALYSIS BY INGREDIENT
  188.   6.27 SPAIN MARKET ANALYSIS BY INDICATION
  189.   6.28 REST OF EUROPE MARKET ANALYSIS BY TYPE
  190.   6.29 REST OF EUROPE MARKET ANALYSIS BY INGREDIENT
  191.   6.30 REST OF EUROPE MARKET ANALYSIS BY INDICATION
  192.   6.31 APAC MARKET ANALYSIS
  193.   6.32 CHINA MARKET ANALYSIS BY TYPE
  194.   6.33 CHINA MARKET ANALYSIS BY INGREDIENT
  195.   6.34 CHINA MARKET ANALYSIS BY INDICATION
  196.   6.35 INDIA MARKET ANALYSIS BY TYPE
  197.   6.36 INDIA MARKET ANALYSIS BY INGREDIENT
  198.   6.37 INDIA MARKET ANALYSIS BY INDICATION
  199.   6.38 JAPAN MARKET ANALYSIS BY TYPE
  200.   6.39 JAPAN MARKET ANALYSIS BY INGREDIENT
  201.   6.40 JAPAN MARKET ANALYSIS BY INDICATION
  202.   6.41 SOUTH KOREA MARKET ANALYSIS BY TYPE
  203.   6.42 SOUTH KOREA MARKET ANALYSIS BY INGREDIENT
  204.   6.43 SOUTH KOREA MARKET ANALYSIS BY INDICATION
  205.   6.44 MALAYSIA MARKET ANALYSIS BY TYPE
  206.   6.45 MALAYSIA MARKET ANALYSIS BY INGREDIENT
  207.   6.46 MALAYSIA MARKET ANALYSIS BY INDICATION
  208.   6.47 THAILAND MARKET ANALYSIS BY TYPE
  209.   6.48 THAILAND MARKET ANALYSIS BY INGREDIENT
  210.   6.49 THAILAND MARKET ANALYSIS BY INDICATION
  211.   6.50 INDONESIA MARKET ANALYSIS BY TYPE
  212.   6.51 INDONESIA MARKET ANALYSIS BY INGREDIENT
  213.   6.52 INDONESIA MARKET ANALYSIS BY INDICATION
  214.   6.53 REST OF APAC MARKET ANALYSIS BY TYPE
  215.   6.54 REST OF APAC MARKET ANALYSIS BY INGREDIENT
  216.   6.55 REST OF APAC MARKET ANALYSIS BY INDICATION
  217.   6.56 SOUTH AMERICA MARKET ANALYSIS
  218.   6.57 BRAZIL MARKET ANALYSIS BY TYPE
  219.   6.58 BRAZIL MARKET ANALYSIS BY INGREDIENT
  220.   6.59 BRAZIL MARKET ANALYSIS BY INDICATION
  221.   6.60 MEXICO MARKET ANALYSIS BY TYPE
  222.   6.61 MEXICO MARKET ANALYSIS BY INGREDIENT
  223.   6.62 MEXICO MARKET ANALYSIS BY INDICATION
  224.   6.63 ARGENTINA MARKET ANALYSIS BY TYPE
  225.   6.64 ARGENTINA MARKET ANALYSIS BY INGREDIENT
  226.   6.65 ARGENTINA MARKET ANALYSIS BY INDICATION
  227.   6.66 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
  228.   6.67 REST OF SOUTH AMERICA MARKET ANALYSIS BY INGREDIENT
  229.   6.68 REST OF SOUTH AMERICA MARKET ANALYSIS BY INDICATION
  230.   6.69 MEA MARKET ANALYSIS
  231.   6.70 GCC COUNTRIES MARKET ANALYSIS BY TYPE
  232.   6.71 GCC COUNTRIES MARKET ANALYSIS BY INGREDIENT
  233.   6.72 GCC COUNTRIES MARKET ANALYSIS BY INDICATION
  234.   6.73 SOUTH AFRICA MARKET ANALYSIS BY TYPE
  235.   6.74 SOUTH AFRICA MARKET ANALYSIS BY INGREDIENT
  236.   6.75 SOUTH AFRICA MARKET ANALYSIS BY INDICATION
  237.   6.76 REST OF MEA MARKET ANALYSIS BY TYPE
  238.   6.77 REST OF MEA MARKET ANALYSIS BY INGREDIENT
  239.   6.78 REST OF MEA MARKET ANALYSIS BY INDICATION
  240.   6.79 KEY BUYING CRITERIA OF HEALTHCARE
  241.   6.80 RESEARCH PROCESS OF MRFR
  242.   6.81 DRO ANALYSIS OF HEALTHCARE
  243.   6.82 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  244.   6.83 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  245.   6.84 SUPPLY / VALUE CHAIN: HEALTHCARE
  246.   6.85 HEALTHCARE, BY TYPE, 2024 (% SHARE)
  247.   6.86 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
  248.   6.87 HEALTHCARE, BY INGREDIENT, 2024 (% SHARE)
  249.   6.88 HEALTHCARE, BY INGREDIENT, 2024 TO 2035 (USD Billion)
  250.   6.89 HEALTHCARE, BY INDICATION, 2024 (% SHARE)
  251.   6.90 HEALTHCARE, BY INDICATION, 2024 TO 2035 (USD Billion)
  252.   6.91 BENCHMARKING OF MAJOR COMPETITORS
  253. 7 LIST OF TABLES
  254.   7.1 LIST OF ASSUMPTIONS
  255.     7.1.1
  256.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  257.     7.2.1 BY TYPE, 2025-2035 (USD Billion)
  258.     7.2.2 BY INGREDIENT, 2025-2035 (USD Billion)
  259.     7.2.3 BY INDICATION, 2025-2035 (USD Billion)
  260.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  261.     7.3.1 BY TYPE, 2025-2035 (USD Billion)
  262.     7.3.2 BY INGREDIENT, 2025-2035 (USD Billion)
  263.     7.3.3 BY INDICATION, 2025-2035 (USD Billion)
  264.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  265.     7.4.1 BY TYPE, 2025-2035 (USD Billion)
  266.     7.4.2 BY INGREDIENT, 2025-2035 (USD Billion)
  267.     7.4.3 BY INDICATION, 2025-2035 (USD Billion)
  268.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  269.     7.5.1 BY TYPE, 2025-2035 (USD Billion)
  270.     7.5.2 BY INGREDIENT, 2025-2035 (USD Billion)
  271.     7.5.3 BY INDICATION, 2025-2035 (USD Billion)
  272.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  273.     7.6.1 BY TYPE, 2025-2035 (USD Billion)
  274.     7.6.2 BY INGREDIENT, 2025-2035 (USD Billion)
  275.     7.6.3 BY INDICATION, 2025-2035 (USD Billion)
  276.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  277.     7.7.1 BY TYPE, 2025-2035 (USD Billion)
  278.     7.7.2 BY INGREDIENT, 2025-2035 (USD Billion)
  279.     7.7.3 BY INDICATION, 2025-2035 (USD Billion)
  280.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  281.     7.8.1 BY TYPE, 2025-2035 (USD Billion)
  282.     7.8.2 BY INGREDIENT, 2025-2035 (USD Billion)
  283.     7.8.3 BY INDICATION, 2025-2035 (USD Billion)
  284.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  285.     7.9.1 BY TYPE, 2025-2035 (USD Billion)
  286.     7.9.2 BY INGREDIENT, 2025-2035 (USD Billion)
  287.     7.9.3 BY INDICATION, 2025-2035 (USD Billion)
  288.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  289.     7.10.1 BY TYPE, 2025-2035 (USD Billion)
  290.     7.10.2 BY INGREDIENT, 2025-2035 (USD Billion)
  291.     7.10.3 BY INDICATION, 2025-2035 (USD Billion)
  292.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  293.     7.11.1 BY TYPE, 2025-2035 (USD Billion)
  294.     7.11.2 BY INGREDIENT, 2025-2035 (USD Billion)
  295.     7.11.3 BY INDICATION, 2025-2035 (USD Billion)
  296.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  297.     7.12.1 BY TYPE, 2025-2035 (USD Billion)
  298.     7.12.2 BY INGREDIENT, 2025-2035 (USD Billion)
  299.     7.12.3 BY INDICATION, 2025-2035 (USD Billion)
  300.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  301.     7.13.1 BY TYPE, 2025-2035 (USD Billion)
  302.     7.13.2 BY INGREDIENT, 2025-2035 (USD Billion)
  303.     7.13.3 BY INDICATION, 2025-2035 (USD Billion)
  304.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  305.     7.14.1 BY TYPE, 2025-2035 (USD Billion)
  306.     7.14.2 BY INGREDIENT, 2025-2035 (USD Billion)
  307.     7.14.3 BY INDICATION, 2025-2035 (USD Billion)
  308.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  309.     7.15.1 BY TYPE, 2025-2035 (USD Billion)
  310.     7.15.2 BY INGREDIENT, 2025-2035 (USD Billion)
  311.     7.15.3 BY INDICATION, 2025-2035 (USD Billion)
  312.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  313.     7.16.1 BY TYPE, 2025-2035 (USD Billion)
  314.     7.16.2 BY INGREDIENT, 2025-2035 (USD Billion)
  315.     7.16.3 BY INDICATION, 2025-2035 (USD Billion)
  316.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  317.     7.17.1 BY TYPE, 2025-2035 (USD Billion)
  318.     7.17.2 BY INGREDIENT, 2025-2035 (USD Billion)
  319.     7.17.3 BY INDICATION, 2025-2035 (USD Billion)
  320.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  321.     7.18.1 BY TYPE, 2025-2035 (USD Billion)
  322.     7.18.2 BY INGREDIENT, 2025-2035 (USD Billion)
  323.     7.18.3 BY INDICATION, 2025-2035 (USD Billion)
  324.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  325.     7.19.1 BY TYPE, 2025-2035 (USD Billion)
  326.     7.19.2 BY INGREDIENT, 2025-2035 (USD Billion)
  327.     7.19.3 BY INDICATION, 2025-2035 (USD Billion)
  328.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  329.     7.20.1 BY TYPE, 2025-2035 (USD Billion)
  330.     7.20.2 BY INGREDIENT, 2025-2035 (USD Billion)
  331.     7.20.3 BY INDICATION, 2025-2035 (USD Billion)
  332.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  333.     7.21.1 BY TYPE, 2025-2035 (USD Billion)
  334.     7.21.2 BY INGREDIENT, 2025-2035 (USD Billion)
  335.     7.21.3 BY INDICATION, 2025-2035 (USD Billion)
  336.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  337.     7.22.1 BY TYPE, 2025-2035 (USD Billion)
  338.     7.22.2 BY INGREDIENT, 2025-2035 (USD Billion)
  339.     7.22.3 BY INDICATION, 2025-2035 (USD Billion)
  340.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  341.     7.23.1 BY TYPE, 2025-2035 (USD Billion)
  342.     7.23.2 BY INGREDIENT, 2025-2035 (USD Billion)
  343.     7.23.3 BY INDICATION, 2025-2035 (USD Billion)
  344.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  345.     7.24.1 BY TYPE, 2025-2035 (USD Billion)
  346.     7.24.2 BY INGREDIENT, 2025-2035 (USD Billion)
  347.     7.24.3 BY INDICATION, 2025-2035 (USD Billion)
  348.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  349.     7.25.1 BY TYPE, 2025-2035 (USD Billion)
  350.     7.25.2 BY INGREDIENT, 2025-2035 (USD Billion)
  351.     7.25.3 BY INDICATION, 2025-2035 (USD Billion)
  352.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  353.     7.26.1 BY TYPE, 2025-2035 (USD Billion)
  354.     7.26.2 BY INGREDIENT, 2025-2035 (USD Billion)
  355.     7.26.3 BY INDICATION, 2025-2035 (USD Billion)
  356.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  357.     7.27.1 BY TYPE, 2025-2035 (USD Billion)
  358.     7.27.2 BY INGREDIENT, 2025-2035 (USD Billion)
  359.     7.27.3 BY INDICATION, 2025-2035 (USD Billion)
  360.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  361.     7.28.1 BY TYPE, 2025-2035 (USD Billion)
  362.     7.28.2 BY INGREDIENT, 2025-2035 (USD Billion)
  363.     7.28.3 BY INDICATION, 2025-2035 (USD Billion)
  364.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  365.     7.29.1 BY TYPE, 2025-2035 (USD Billion)
  366.     7.29.2 BY INGREDIENT, 2025-2035 (USD Billion)
  367.     7.29.3 BY INDICATION, 2025-2035 (USD Billion)
  368.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  369.     7.30.1 BY TYPE, 2025-2035 (USD Billion)
  370.     7.30.2 BY INGREDIENT, 2025-2035 (USD Billion)
  371.     7.30.3 BY INDICATION, 2025-2035 (USD Billion)
  372.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  373.     7.31.1
  374.   7.32 ACQUISITION/PARTNERSHIP
  375.     7.32.1

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • hard candy lozenges
  • soft lozenges
  • compressed lozenges

Healthcare By Ingredient (USD Billion, 2025-2035)

  • menthol
  • mint
  • eucalyptus oil
  • peppermint oil
  • honey & ginger
  • lemon
  • others

Healthcare By Indication (USD Billion, 2025-2035)

  • sore throat
  • cough and cold
  • throat diseases

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions